Shanghai Fosun, China Fund Buy Nearly All Of Israel's Alma Lasers
This article was originally published in PharmAsia News
Executive Summary
Shanghai Fosun Pharmaceutical and Primaerica-Fosun Fund jointly acquired nearly all of Israel's Alma Lasers, maker of medical lasers, primarily for cosmetic treatments.